About Madrigal
Madrigal is a company based in Lexington (United States) founded in 2000. It operates as a HealthTech. Madrigal has raised $90 million across 3 funding rounds from investors including Caxton Associates, Galleon Group and Military Health. The company has 37 employees as of December 31, 2022. Madrigal has completed 1 acquisition, including Madrigal Pharmaceuticals. Madrigal offers products and services including MASH Treatment. Madrigal operates in a competitive market with competitors including Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others.
- Headquarter Lexington, United States
- Employees 37 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Madrigal Pharmaceuticals, Inc.
-
Annual Revenue
$180.13 M0as on Dec 31, 2024
-
Net Profit
$-465.89 M-25as on Dec 31, 2024
-
EBITDA
$-497.88 M-31as on Dec 31, 2024
-
Total Equity Funding
$90 M (USD)
in 3 rounds
-
Latest Funding Round
$999.7 K (USD), Grant
Apr 01, 2011
-
Investors
Caxton Associates
& 2 more
-
Employee Count
37
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Madrigal
Madrigal offers a comprehensive portfolio of products and services, including MASH Treatment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A treatment for metabolic dysfunction-associated steatohepatitis is provided.
Unlock access to complete
Area Team
78 people
Leadership Team
68 people
Sales and Marketing
26 people
Operations Team
20 people
Thought Team
13 people
Data Analysis and Operations Team
12 people
Software Development Team
12 people
Product Management Team
11 people
Unlock access to complete
Funding Insights of Madrigal
Madrigal has successfully raised a total of $90M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $999.7 thousand completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $999,699
-
First Round
First Round
(12 Jan 2004)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2011 | Amount | Grant - Madrigal | Valuation |
investors |
|
| Oct, 2006 | Amount | Private Equity Round - Madrigal | Valuation |
investors |
|
| Jan, 2004 | Amount | Series C - Madrigal | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Madrigal
Madrigal has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Caxton Associates, Galleon Group and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified asset management is provided by Caxton Associates.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Madrigal
Madrigal has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Madrigal Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops small molecule drugs for the treatment of cardiovascular and metabolic diseases and non-alcoholic steatohepatitis
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Madrigal
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Madrigal Comparisons
Competitors of Madrigal
Madrigal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adicet Bio, Orca Bio, Ossium Health, Auron Therapeutics and Nordic Nanovector, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immune cell therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Ossium Health is focused on bioengineering for improved health.
|
|
| domain | founded_year | HQ Location |
Developer of cancer therapeutics for the treatment of blood cancer
|
|
| domain | founded_year | HQ Location |
Antibody radionuclide conjugates are developed for haematological cancers.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody therapies for pediatric leukemia are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Madrigal
When was Madrigal founded?
Madrigal was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Where is Madrigal located?
Madrigal is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Madrigal a funded company?
Madrigal is a funded company, having raised a total of $90M across 3 funding rounds to date. The company's 1st funding round was a Series C of $50M, raised on Jan 12, 2004.
How many employees does Madrigal have?
As of Dec 31, 2022, the latest employee count at Madrigal is 37.
What is the annual revenue of Madrigal?
Annual revenue of Madrigal is $180.13M as on Dec 31, 2024.
What does Madrigal do?
Madrigal Pharmaceuticals, Inc. is engaged in developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a severe liver condition. The companys efforts are directed towards halting or reversing liver scarring and resolving MASH to prevent complications like cirrhosis. Operating within the biopharmaceutical sector, Madrigal has achieved a significant milestone with the first FDA-approved treatment for MASH. Their solutions target high unmet medical needs in liver disease management across the United States and Europe.
Who are the top competitors of Madrigal?
Madrigal's top competitors include Orca Bio, Ossium Health and Adicet Bio.
What products or services does Madrigal offer?
Madrigal offers MASH Treatment.
How many acquisitions has Madrigal made?
Madrigal has made 1 acquisition, including Madrigal Pharmaceuticals.
Who are Madrigal's investors?
Madrigal has 3 investors. Key investors include Caxton Associates, Galleon Group, and Military Health.